Unifying mechanism in the initiation of breast cancer by metabolism of estrogen (Review)
- Authors:
- Chunjie Wen
- Lanxiang Wu
- Lijuan Fu
- Bing Wang
- Honghao Zhou
-
Affiliations: Institute of Life Sciences, Chongqing Medical University, Chongqing 400016, P.R. China, Institute of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, P.R. China - Published online on: June 9, 2017 https://doi.org/10.3892/mmr.2017.6738
- Pages: 1001-1006
This article is mentioned in:
Abstract
 |
|
DeSantis C, Siegel R, Bandi P and Jemal A: Breast cancer statistics. CA Cancer J Clin. 61:409–418. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Santen RJ, Boyd NF, Chlebowski RT, Cummings S, Cuzick J, Dowsett M, Easton D, Forbes JF, Key T, Hankinson SE, et al: Critical assessment of new risk factors for breast cancer: Considerations for development of an improved risk prediction model. Endocr Relat Cancer. 14:169–187. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hofseth LJ, Raafat AM, Osuch JR, Pathak DR, Slomski CA and Haslam SZ: Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab. 84:4559–4565. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Cavalieri E and Rogan E: The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med. 36:1–55. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Devanesan P, Santen RJ, Bocchinfuso WP, Korach KS, Rogan EG and Cavalieri E: Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: Implications for initiation of mammary tumors. Carcinogenesis. 22:1573–1576. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, et al: Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA. 94:10937–10942. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Li KM, Todorovic R, Devanesan P, Higginbotham S, Köfeler H, Ramanathan R, Gross ML, Rogan EG and Cavalieri EL: Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo. Carcinogenesis. 25:289–297. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Cavalieri EL and Rogan EG: Depurinating estrogen-DNA adducts in the etiology and prevention of breast and other human cancers. Future Oncol. 6:75–91. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Fussell KC, Udasin RG, Smith PJ, Gallo MA and Laskin JD: Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells. Carcinogenesis. 32:1285–1293. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Valko M, Rhodes CJ, Moncol J, Izakovic M and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 160:1–40. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lee AJ, Cai MX, Thomas PE, Conney AH and Zhu BT: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology. 144:3382–3398. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, et al: Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr. 95–112. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Rahman M, Lax SF, Sutter CH, Tran QT, Stevens GL, Emmert GL, Russo J, Santen RJ and Sutter TR: CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma. Drug Metab Dispos. 36:963–970. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Pruthi S, Yang L, Sandhu NP, Ingle JN, Beseler CL, Suman VJ, Cavalieri EL and Rogan EG: Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk. J Steroid Biochem Mol Biol. 132:73–79. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Salama SA, Kamel M, Awad M, Nasser AH, Al-Hendy A, Botting S and Arrastia C: Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: Protective effect of catechol-O-methyltransferase. Int J Cancer. 123:1246–1254. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yager JD: Catechol-O-methyltransferase: Characteristics, polymorphisms and role in breast cancer. Drug Discov Today Dis Mech. 9:e41–e46. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Lavigne JA, Goodman JE, Fonong T, Odwin S, He P, Roberts DW and Yager JD: The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Cancer Res. 61:7488–7494. 2001.PubMed/NCBI | |
|
Zahid M, Saeed M, Lu F, Gaikwad N, Rogan E and Cavalieri E: Inhibition of catechol-O-methyltransferase increases estrogen-DNA adduct formation. Free Radic Biol Med. 43:1534–1540. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu BT and Conney AH: Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58:2269–2277. 1998.PubMed/NCBI | |
|
Gaikwad NW, Rogan EG and Cavalieri EL: Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med. 43:1289–1298. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cavalieri E, Rogan E and Chakravarti D: The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases. Methods Enzymol. 382:293–319. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Cavalieri EL and Rogan EG: A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci. 1028:247–257. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Stack DE, Li G, Hill A and Hoffman N: Mechanistic insights into the Michael addition of deoxyguanosine to catechol estrogen-3,4-quinones. Chem Res Toxicol. 21:1415–1425. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Bolton JL and Shen L: p-Quinone methides are the major decomposition products of catechol estrogen o-quinones. Carcinogenesis. 17:925–929. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Zahid M, Kohli E, Saeed M, Rogan E and Cavalieri E: The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: Implications for tumor-initiating activity. Chem Res Toxicol. 19:164–172. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lu F, Zahid M, Saeed M, Cavalieri EL and Rogan EG: Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol. 105:150–158. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL and Rogan EG: Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res. 1:135–145. 2008. View Article : Google Scholar | |
|
Saeed M, Rogan E, Fernandez SV, Sheriff F, Russo J and Cavalieri E: Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol. Int J Cancer. 120:1821–1824. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Russo J and Russo IH: Genotoxicity of steroidal estrogens. Trends Endocrinol Metab. 15:211–214. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Russo J, Lareef M Hasan, Balogh G, Guo S and Russo IH: Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol. 87:1–25. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Lareef MH, Garber J, Russo PA, Russo IH, Heulings R and Russo J: The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol. 26:423–429. 2005.PubMed/NCBI | |
|
Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG and Cavalieri EL: Genotoxic metabolites of estradiol in breast: Potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol. 86:477–486. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J and Yue W: Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann NY Acad Sci. 1155:132–140. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chakravarti D, Mailander PC, Li KM, Higginbotham S, Zhang HL, Gross ML, Meza JL, Cavalieri EL and Rogan EG: Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene. Oncogene. 20:7945–7953. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Mailander PC, Meza JL, Higginbotham S and Chakravarti D: Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats. J Steroid Biochem Mol Biol. 101:204–215. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG and Guttenplan JB: Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol. 19:475–479. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Gaikwad NW, Yang L, Muti P, Meza JL, Pruthi S, Ingle JN, Rogan EG and Cavalieri EL: The molecular etiology of breast cancer: Evidence from biomarkers of risk. Int J Cancer. 122:1949–1957. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gaikwad NW, Yang L, Pruthi S, Ingle JN, Sandhu N, Rogan EG and Cavalieri EL: Urine biomarkers of risk in the molecular etiology of breast cancer. Breast Cancer. 3:1–8. 2009.PubMed/NCBI | |
|
Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R and Sutter T: Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 1766:63–78. 2006.PubMed/NCBI | |
|
Tian H, Gao Z, Wang G, Li H and Zheng J: Estrogen potentiates reactive oxygen species (ROS) tolerance to initiate carcinogenesis and promote cancer malignant transformation. Tumour Biol. 37:141–150. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Okoh VO, Felty Q, Parkash J, Poppiti R and Roy D: Reactive oxygen species via redox signaling to PI3K/AKT pathway contribute to the malignant growth of 4-hydroxy estradiol-transformed mammary epithelial cells. PLoS One. 8:e542062013. View Article : Google Scholar : PubMed/NCBI | |
|
Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J and Roy D: Estrogen-induced mitochondrial reactive oxygen species as signal-transducing messengers. Biochemistry. 44:6900–6909. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y and Hayashi J: ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 320:661–664. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Doan VD, Gagnon S and Joseph V: Prenatal blockade of estradiol synthesis impairs respiratory and metabolic responses to hypoxia in newborn and adult rats. Am J Physiol Regul Integr Comp Physiol. 287:R612–R618. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tan DJ, Bai RK and Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62:972–976. 2002.PubMed/NCBI | |
|
Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez R, Lau AW, Hafer LJ, Yaswen P, Stampfer M, Rogers AE, et al: Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis. 21:871–879. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Park SA, Na HK, Kim EH, Cha YN and Surh YJ: 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: Potential role of reactive oxygen species. Cancer Res. 69:2416–2424. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Benhar M, Engelberg D and Levitzki A: ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 3:420–425. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Hanna IH, Dawling S, Roodi N, Guengerich FP and Parl FF: Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res. 60:3440–3444. 2000.PubMed/NCBI | |
|
Delort L, Satih S, Kwiatkowski F, Bignon YJ and Bernard-Gallon DJ: Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms. Nutr Cancer. 62:243–251. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Bandiera S, Weidlich S, Harth V, Broede P, Ko Y and Friedberg T: Proteasomal degradation of human CYP1B1: Effect of the Asn453Ser polymorphism on the post-translational regulation of CYP1B1 expression. Mol Pharmacol. 67:435–443. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Matyjasik J, Cybulski C, Masojć B, Jakubowska A, Serrano-Fernandez P, Górski B, Debniak T, Huzarski T, Byrski T, Gronwald J, et al: CYP1B1 and predisposition to breast cancer in Poland. Breast Cancer Res Treat. 106:383–388. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, et al: Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics. 16:547–553. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Jiao H, Liu C, Guo W, Peng L, Chen Y and Martin FL: Association of CYP1B1 Polymorphisms with Breast Cancer: A Case-Control Study in the Han Population in Ningxia Hui Autonomous Region, P. R. China. Biomark Insights. 5:21–27. 2010.PubMed/NCBI | |
|
Masson LF, Sharp L, Cotton SC and Little J: Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: A HuGE review. Am J Epidemiol. 161:901–915. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Huang Y, Li Y, Mao Y and Xie Y: Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: A meta-analysis. J Hum Genet. 52:423–435. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sergentanis TN and Economopoulos KP: Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: A meta-analysis. Breast Cancer Res Treat. 122:459–469. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Shield AJ, Thomae BA, Eckloff BW, Wieben ED and Weinshilboum RM: Human catechol O-methyltransferase genetic variation: Gene resequencing and functional characterization of variant allozymes. Mol Psychiatry. 9:151–160. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Doyle AE and Yager JD: Catechol-O-methyltransferase: Effects of the val108met polymorphism on protein turnover in human cells. Biochim Biophys Acta. 1780:27–33. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Tian C, Liu L, Yang X, Wu H and Ouyang Q: The Val158Met polymorphism in the COMT gene is associated with increased cancer risks in Chinese population. Tumour Biol. 35:3003–3008. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wan GX, Cao YW, Li WQ, Li YC and Li F: The catechol-O-methyltransferase Val158Met polymorphism contributes to the risk of breast cancer in the chinese population: an updated meta-analysis. J Breast Cancer. 17:149–156. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li K, Li W and Zou H: Catechol-O-methyltransferase Val158Met polymorphism and breast cancer risk in Asian population. Tumour Biol. 35:2343–2350. 2014. View Article : Google Scholar : PubMed/NCBI |
